“…(4) effects of DTC drug advertising on non-consumer stakeholders and the health care system; (5) attitudes and behaviors of health care professionals toward DTC drug advertising; (6) DTC drug advertising public policy and regulatory issues; (7) message content of DTC drug advertising; and (8) content and format of DTC drug web sites (e.g., Allison-Ottey, Ruffin, and Allison 2002;Balazs, Yermolivich, and Zinkhan 2000;Bell, Wilkes, and Kravitz 2000;Calfee 2002;Coney 2002;Davis 2000;Deshpande et al 2003;FDA 1999;Findlay 2001;Graber and Weckmann 2002;Gonul, Carter, and Wind 2000;Hoek and Gendall 2002;Huh and Becker 2002;Kopp and Bang 2000;Macias and Lewis 2002;Menon et al 2003aMenon et al , 2003bWilkes, Bell, and Kravitz 2000;Zachary et al 2002).…”